The estimated Net Worth of Robert Lorne Abel is at least 5.43 百万$ dollars as of 12 February 2024. Mr. Abel owns over 1,205 units of Schrodinger stock worth over 192,217$ and over the last 5 years he sold SDGR stock worth over 5,239,306$. In addition, he makes 0$ as Executive Vice President - science at Schrodinger.
Sign up
Mr. Abel SDGR stock SEC Form 4 insiders trading
Robert has made over 8 trades of the Schrodinger stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 1,205 units of SDGR stock worth 33,198$ on 12 February 2024.
The largest trade he's ever made was selling 42,628 units of Schrodinger stock on 11 December 2020 worth over 3,079,873$. On average, Robert trades about 11,787 units every 85 days since 2020. As of 12 February 2024 he still owns at least 9,340 units of Schrodinger stock.
You can see the complete history of Mr. Abel stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Robert Abel biography
Dr. Robert Abel Ph.D. serves as Executive Vice President - science of the Company. Mr. Abel has been with our company for over 10 years and previously served as our senior vice president, science, from April 2017 to December 2019, vice president, scientific development from January 2014 to April 2017, director of structure-based science from January 2011 to December 2013, senior principal scientist and product manager from January 2010 to December 2010 and senior scientist from March 2009 to December 2009. Dr. Abel received a B.S. in Chemistry from the University of Florida and a Ph.D. in Chemical Physics from University of Florida . In graduate school, Dr. Abel was a National Science Foundation Graduate Research Fellow and a Department of Homeland Security Research Fellow, and worked from May 2005 to August 2005 at Los Alamos National Laboratory under the auspices of the DHS Research Fellowship.
How old is Robert Abel?
Robert Abel is 37, he's been the Executive Vice President - science of Schrodinger since 2020. There are 20 older and 1 younger executives at Schrodinger. The oldest executive at Schrodinger, Inc. is Dr. Richard A. Friesner, 68, who is the Co-Founder, Scientific Advisory Chairman and Director.
What's Robert Abel's mailing address?
Robert's mailing address filed with the SEC is C/O SCHRODINGER, INC.,, 1540 BROADWAY, 24TH FLOOR, NEW YORK, NY, 10036.
Insiders trading at Schrodinger
Over the last 5 years, insiders at Schrodinger have traded over 1,009,056,149$ worth of Schrodinger stock and bought 838,235 units worth 14,249,995$ . The most active insiders traders include & Melinda Gates Foundation ...、David E Schrodinger Equity ...、Michael Lynton. On average, Schrodinger executives and independent directors trade stock every 10 days with the average trade being worth of 2,459,207$. The most recent stock trade was executed by Kenneth Patrick Lorton on 6 March 2024, trading 5,574 units of SDGR stock currently worth 24,191$.
What does Schrodinger do?
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
What does Schrodinger's logo look like?
Complete history of Mr. Abel stock trades at Schrodinger
Schrodinger executives and stock owners
Schrodinger executives and other stock owners filed with the SEC include:
-
Dr. Ramy Farid Ph.D.,
CEO, Pres & Director -
Yvonne Tran Esq.,
Exec. VP, Chief Legal Officer & Sec. -
Dr. Karen Akinsanya Ph.D.,
Exec. VP, Chief Biomedical Scientist and Head of Discovery R&D -
Ramy Farid,
President, Chief Executive Officer, Director -
Cony D cruz,
Executive Vice President - Chief Business Officer -
Yvonne Tran,
Executive Vice President, Chief Legal Officer -
Dr. Richard A. Friesner,
Co-Founder, Scientific Advisory Chairman and Director -
Richard Friesner,
Independent Director -
Nancy Thornberry,
Independent Director -
Gary Sender,
Independent Director -
Rosana Kapeller-Libermann,
Independent Director -
Timothy Wright,
Independent Director -
Shane Brauner,
Senior Vice President, Chief Information Officer -
Kenneth Lorton,
Senior Vice President, Chief Technology Officer -
Karen Akinsanya,
Executive Vice President, Chief Biomedical Scientist, Head of Discovery R&D -
Robert Abel,
Executive Vice President - science -
Jorg Weiser,
Executive Vice President, Managing Director -
Jennifer Daniel,
Chief Human Resource Officer, Senior Vice President -
Joel Lebowitz,
Executive Vice President, Chief Financial Officer -
Michael Lynton,
Independent Chairman of the Board of Directors -
Michelle Byington,
VP of HR -
Jennifer Mayer Daniel,
Sr. VP & Chief HR Officer -
Jaren Irene Madden,
Sr. VP of Investor Relations & Corp. Communications -
Shane Brauner,
Exec. VP & Chief Information Officer -
Kenneth Patrick Lorton,
Exec. VP & CTO -
Prof. William Goddard III,
Co-Founder & Scientific Advisor -
Charles Ardai,
10% owner -
Geoffrey Craig Porges,
EVP & CFO -
David E Shaw,
10% owner -
Gary L Ginsberg,
Director -
Jeffrey Chodakewitz,
Director -
& Melinda Gates Foundation ...,
10% owner -
David E Schrodinger Equity ...,
-
James E Deerfield Mgmt Iv, ...,
-
Jenny Herman,
SVP & Controller -
Arun Oberoi,
Director -
Margaret Dugan,
Chief Medical Officer